|
Catalog Number 466P306X |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Embolus (1830)
|
Event Date 10/18/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
Additional information is pending and will be submitted within 30 days upon receipt.
|
|
Event Description
|
As reported by the legal brief, the patient underwent placement of a trapease vena cava filter.The filter subsequently malfunctioned and caused injury and damage, including, but not limited to the filter is still in place, and recent studies confirm the filter now presents more risks than benefits, including an increased risk of forming a blood clot.The extent of the device failure has not been fully documented by patient¿s treating medical provider(s).As a result of the malfunction, the patient has or may suffer life-threatening injuries and damages and require extensive medical care and treatment.Patient has or may suffer and will continue to suffer significant medical expenses, extreme pain and suffering, loss of enjoyment of life, disability, and other losses.Patient will require continued close monitoring of the filter, medications to reduce the risks of new blood clots, and may need a risky surgery to attempt to remove the filter.
|
|
Manufacturer Narrative
|
It was reported that a patient underwent placement of a trapease vena cava filter.The information provided indicated that the filter subsequently malfunctioned and caused an increased risk of forming a blood clot.The indication for the filter implant has not been provided and there is currently no additional information available for review.The product was not returned for analysis and the sterile lot number has not been provided; therefore, no device analysis nor device history record review could be performed.The trapease vena cava filter is indicated for use in the prevention of recurrent pulmonary embolism (pe) via percutaneous placement in the vena cava for patients in which anticoagulants are contraindicated, anticoagulant therapy for thromboembolic disease has failed, emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced or for chronic, recurrent pulmonary embolism where anticoagulant therapy has failed, or is contraindicated.The purpose of a vena cava filter is to catch thrombus from the lower extremities as it travels along normal blood flow patterns up towards the heart.Blood clots, clotting and/or occlusion of the ivc or surrounding vasculature does not represent a device malfunction.Rather, patient, vessel characteristics and/or pharmacological factors may have contributed to these events.With the limited information provided it is not possible to determine a cause for or further clarify the reported events.Given the limited information currently available for review, there is nothing to suggest that the reported events are related to the design and manufacturing process of the device; therefore, no corrective action will be taken.Should additional information become available, the file will be updated accordingly.
|
|
Manufacturer Narrative
|
As reported, the patient underwent placement of a trapease inferior vena cava (ivc) filter.Per the medical records state that the patient has a medical history of multiple myeloma, left lower extremity dvt and pulmonary emboli.During the implant procedure, the right femoral vein was accessed.The infrarenal position was chosen for placement of the trapease filter.The filter subsequently malfunctioned and caused injury and damage, including, but not limited to the filter is still in place, and recent studies confirm the filter now presents more risks than benefits, including an increased risk of forming a blood clot.According to the information received in the patient profile form (ppf), the patient reports mental anguish due to the filter.The product was not returned for analysis and the sterile lot number has not been provided; therefore, no device analysis nor device history record review could be performed.The trapease vena cava filter is indicated for use in the prevention of recurrent pulmonary embolism (pe) via percutaneous placement in the vena cava for patients in which anticoagulants are contraindicated, anticoagulant therapy for thromboembolic disease has failed, emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced or for chronic, recurrent pulmonary embolism where anticoagulant therapy has failed, or is contraindicated.The purpose of a vena cava filter is to catch thrombus from the lower extremities as it travels along normal blood flow patterns up towards the heart.Without images or procedural films for review, no device malfunction could be confirmed.Anxiety does not represent a device malfunction and may be related to underlying patient related issues.Clinical factors that may have influenced the event include patient, pharmacological and lesion characteristics.Without procedural films or images for review the reported event(s) could not be confirmed.Given the limited information available for review at this time, there is nothing to suggest that the reported events are related to the design and manufacturing process of the device; therefore, no corrective action will be taken.Should additional information become available, the file will be updated accordingly.
|
|
Search Alerts/Recalls
|
|
|